Literature DB >> 21500354

A tetrazolato-bridged dinuclear platinum(II) complex exhibits markedly high in vivo antitumor activity against pancreatic cancer.

Seiji Komeda1, Yuh-Ling Lin, Masahiko Chikuma.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21500354     DOI: 10.1002/cmdc.201100141

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


× No keyword cloud information.
  4 in total

1.  DNA Conformational Changes Induced by Its Interaction with Binuclear Platinum Complexes in Solution Indicate the Molecular Mechanism of Platinum Binding.

Authors:  Nina Kasyanenko; Zhang Qiushi; Vladimir Bakulev; Petr Sokolov; Konstantin Yakovlev
Journal:  Polymers (Basel)       Date:  2022-05-17       Impact factor: 4.967

2.  Data on synthesis and structure-activity relationships of tetrazolato-bridged dinuclear platinum(II) complexes.

Authors:  Seiji Komeda; Hiroki Yoneyama; Masako Uemura; Takahiro Tsuchiya; Miyuu Hoshiyama; Tomoya Sakazaki; Keiichi Hiramoto; Shinya Harusawa
Journal:  Data Brief       Date:  2021-12-10

3.  Anion-Dependent Synthesis of Cu(II) Complexes with 2-(1H-Tetrazol-5-yl)-1H-indole: Synthesis, X-Ray Structures, and Radical Scavenging Activity.

Authors:  Petr Halaš; Juraj Kuchár; Radovan Herchel
Journal:  Bioinorg Chem Appl       Date:  2021-12-21       Impact factor: 7.778

4.  Chromatin folding and DNA replication inhibition mediated by a highly antitumor-active tetrazolato-bridged dinuclear platinum(II) complex.

Authors:  Ryosuke Imai; Seiji Komeda; Mari Shimura; Sachiko Tamura; Satoshi Matsuyama; Kohei Nishimura; Ryan Rogge; Akihiro Matsunaga; Ichiro Hiratani; Hideaki Takata; Masako Uemura; Yutaka Iida; Yuko Yoshikawa; Jeffrey C Hansen; Kazuto Yamauchi; Masato T Kanemaki; Kazuhiro Maeshima
Journal:  Sci Rep       Date:  2016-04-20       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.